PPT-PrEP Scale

Up in Kenya Bridge to Scale Project IAS Satellite Session 25 th July 2017 Dr Elizabeth Irungu Partners Scale up Project Kenya Dr Daniel Were Jhpiego Kenya Background on HIV in Kenya . Clinical trials have shown daily oral . Tenofovir. to effectively prevent HIV acquisition. PrEP must only be prescribed for HIV- patients and patients taking PrEP must have regular tests for HIV and other clinical conditions. . Bridge . to . Scale . Project. IAS Satellite . Session. 25. th. . July . 2017. Dr. Elizabeth . Irungu. Partners Scale up Project, Kenya . Dr. Daniel Were. Jhpiego, Kenya . Background on HIV in Kenya . Module . 1(b). The Evidence in Detail. Session Overview. Seroconversion rates. PrEP. Studies: MSM, transgender population, women, discordant couples. Benefits of . PrEP. Barriers to . PrEP. services. Katherine Marx, MS, MPH, FNP-BC. June 2014. Disclosure. I, Katherine Marx, have no relevant financial, professional, or personal relationships to disclose.. Objectives. Know current US recommendations for . Online ACT Prep Overview Method Test Prep (MTP) What is Method Test Prep? Free, online ACT prep program Available to all South Dakota high school students with the exception of home school students Consists of lessons, quizzes, evaluation tests, vocabulary practice, full length exams divided by subtest Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research and Education and Ronald Reagan Medical Center PrEP and Men: A man’s got to do, what a man’s got to do. Dr Saiqa Mullick, Wits RHI @ WitsRHI Share your thoughts on this presentation with #IAS2019 Context: It’s time for a conversation about male risk Ravipa Vannakit, USAID Regional Development Mission for Asia (RDMA), Bangkok, Thailand July 24, 2018 rvannakit@usaid.gov Key population-led health services (KP-LHS) critical to PrEP introduction among men who have sex with men (MSM) and transgender women (TGW) in Thailand Providing PrEP to Connecticut’s Youth A Training for Healthcare Providers Krystn Wagner, MD Jay Sicklick , JD October 16, 2019 Faculty Krystn Wagner, MD PhD Medical Director, HIV and Infectious Disease Kimberly Green. Director, Primary Health Care. PATH. kgreen@path.org. More than . 1.3 million . people took PrEP at least once by June 2021. Source: Jessica Rodrigues, AVAC, IAS2021. PrEP use has accelerated but is still far from meeting . . PrEP. . in . eswatini. July 24, . 2018. Sindy Matse. Ministry of Health. Why . P. r. EP. in . eswatini. ?. New infections continue to occur in . Eswatini. despite major strides in the national response. . Basics of Injectable Cabotegravir. for HIV Prevention . Draft for Comment . AVAC. March 2022. Outline. What is cabotegravir (CAB)? . Treatment . Prevention . Clinical research. What users think . Regulatory and guidelines. Valdilea. G. . Veloso. @. Valdilea. Share your thoughts on this presentation with . #IAS2019. Conflict of Interest Disclosure. I . have. no . conflit. . of. . interest. . to. report.. National. Welcome to the era of PrEP choice. Rose Nyirenda, Ministry of Health, Malawi. Declining HIV incidence: 0.1% (15-49 years). Generalized epidemic: distribution of 14,000 new infections. 70% in general population (excl. AGYW).